{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T21:59:34Z","timestamp":1791928774233,"version":"4.3.4"},"reference-count":38,"publisher":"Association for Research in Vision and Ophthalmology (ARVO)","issue":"3","license":[{"start":{"date-parts":[[2022,3,17]],"date-time":"2022-03-17T00:00:00Z","timestamp":1647475200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Invest. Ophthalmol. Vis. Sci."],"published-print":{"date-parts":[[2022,3,17]]},"DOI":"10.1167\/iovs.63.3.20","type":"journal-article","created":{"date-parts":[[2022,3,17]],"date-time":"2022-03-17T13:53:33Z","timestamp":1647525213000},"page":"20","source":"Crossref","is-referenced-by-count":10,"title":["SP2509, a Selective Inhibitor of LSD1, Suppresses Retinoblastoma Growth by Downregulating \u03b2-catenin Signaling"],"prefix":"10.1167","volume":"63","author":[{"given":"Alan","family":"Jiang","sequence":"first","affiliation":[{"name":"Jiangxi Provincial Key Laboratory of Tumor Metastasis and Precision Therapy, Center Laboratory, The Third Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, PR China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiqi","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, The Third Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, PR China"},{"name":"Medical Department of Graduate School, Nanchang University, Nanchang, Jiangxi, PR China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caixia","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, The Third Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, PR China"},{"name":"Medical Department of Graduate School, Nanchang University, Nanchang, Jiangxi, PR China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Longbing","family":"Mao","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, The Third Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, PR China"},{"name":"Medical Department of Graduate School, Nanchang University, Nanchang, Jiangxi, PR China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sha","family":"Ao","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, The Third Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, PR China"},{"name":"Medical Department of Graduate School, Nanchang University, Nanchang, Jiangxi, PR China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huifeng","family":"Guo","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, The Third Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, PR China"},{"name":"Medical Department of Graduate School, Nanchang University, Nanchang, Jiangxi, PR China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiantao","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Children's Hospital Affiliated to Zhengzhou University, Henan Children's Hospital, Zhengzhou Children's Hospital, Zhengzhou, Henan, PR China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Tao","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Children's Hospital Affiliated to Zhengzhou University, Henan Children's Hospital, Zhengzhou Children's Hospital, Zhengzhou, Henan, PR China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Sang","sequence":"additional","affiliation":[{"name":"Jiangxi Provincial Key Laboratory of Tumor Metastasis and Precision Therapy, Center Laboratory, The Third Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, PR China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guofu","family":"Huang","sequence":"additional","affiliation":[{"name":"Jiangxi Provincial Key Laboratory of Tumor Metastasis and Precision Therapy, Center Laboratory, The Third Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, PR China"},{"name":"Department of Ophthalmology, The Third Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, PR China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"27","reference":[{"issue":"12","key":"bib1","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1038\/s41388-017-0050-x","article-title":"The management of retinoblastoma","volume":"37","author":"Fabian","year":"2018","journal-title":"Oncogene"},{"issue":"31","key":"bib2","doi-asserted-by":"publisher","first-page":"5338","DOI":"10.1038\/s41388-020-1372-7","article-title":"Functional genomics identifies new synergistic therapies for retinoblastoma","volume":"39","author":"Aubry","year":"2020","journal-title":"Oncogene"},{"issue":"11","key":"bib3","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1038\/nrclinonc.2014.155","article-title":"Cancer therapy: retinoblastoma\u2014chemotherapy increases the risk of secondary cancer","volume":"11","author":"Errico","year":"2014","journal-title":"Nat Rev Clin Oncol"},{"issue":"10","key":"bib4","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1016\/j.molmed.2016.07.010","article-title":"Lessons from retinoblastoma: implications for cancer, development, evolution, and regenerative medicine","volume":"22","author":"Dyer","year":"2016","journal-title":"Trends Mol Med"},{"key":"bib5","doi-asserted-by":"publisher","first-page":"3341","DOI":"10.1007\/s00018-020-03489-9","article-title":"Biological roles of LSD1 beyond its demethylase activity","volume":"77","author":"Gu","year":"2020","journal-title":"Cell Mol Life Sci"},{"issue":"7","key":"bib6","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1016\/j.cell.2004.12.012","article-title":"Histone demethylation mediated by the nuclear amine oxidase homolog LSD1","volume":"119","author":"Shi","year":"2004","journal-title":"Cell"},{"issue":"5","key":"bib7","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1016\/j.molcel.2020.04.019","article-title":"Crystal structure of the LSD1\/CoREST histone demethylase bound to its nucleosome substrate","volume":"78","author":"Kim","year":"2020","journal-title":"Mol Cell"},{"issue":"3","key":"bib8","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/j.ccell.2018.02.002","article-title":"ORY-1001, a potent and selective covalent KDM1A inhibitor, for the treatment of acute leukemia","volume":"33","author":"Maes","year":"2018","journal-title":"Cancer Cell"},{"issue":"5","key":"bib9","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1038\/s41556-020-0503-2","article-title":"Merkel cell polyomavirus activates LSD1-mediated blockade of non-canonical BAF to regulate transformation and tumorigenesis","volume":"22","author":"Park","year":"2020","journal-title":"Nat Cell Biol"},{"issue":"18","key":"bib10","doi-asserted-by":"publisher","first-page":"E4179","DOI":"10.1073\/pnas.1719168115","article-title":"LSD1 activates a lethal prostate cancer gene network independently of its demethylase function","volume":"115","author":"Sehrawat","year":"2018","journal-title":"Proc Natl Acad Sci USA"},{"issue":"11","key":"bib11","doi-asserted-by":"publisher","first-page":"1965","DOI":"10.1002\/mol2.2018.12.issue-11","article-title":"Preclinical studies reveal that LSD1 inhibition results in tumor growth arrest in lung adenocarcinoma independently of driver mutations","volume":"12","author":"Macheleidt","year":"2018","journal-title":"Mol Oncol"},{"issue":"44","key":"bib12","doi-asserted-by":"publisher","first-page":"7017","DOI":"10.1038\/s41388-019-0923-2","article-title":"LSD1 suppresses invasion, migration and metastasis of luminal breast cancer cells via activation of GATA3 and repression of TRIM37 expression","volume":"38","author":"Hu","year":"2019","journal-title":"Oncogene"},{"issue":"1","key":"bib13","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.ccell.2015.06.002","article-title":"A DNA hypomethylation signature predicts antitumor activity of LSD1 inhibitors in SCLC","volume":"28","author":"Mohammad","year":"2015","journal-title":"Cancer Cell"},{"issue":"11","key":"bib14","doi-asserted-by":"publisher","first-page":"2155","DOI":"10.1038\/leu.2014.119","article-title":"Highly effective combination of LSD1 (KDM1A) antagonist and pan-histone deacetylase inhibitor against human AML cells","volume":"28","author":"Fiskus","year":"2014","journal-title":"Leukemia"},{"issue":"2","key":"bib15","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.apsb.2018.10.006","article-title":"LSD1 inhibition suppresses the growth of clear cell renal cell carcinoma via upregulating P21 signaling","volume":"9","author":"Zhu","year":"2019","journal-title":"Acta Pharm Sin B"},{"issue":"9","key":"bib16","doi-asserted-by":"publisher","first-page":"1902","DOI":"10.1158\/1535-7163.MCT-18-0373","article-title":"Therapeutic targeting of KDM1A\/LSD1 in Ewing sarcoma with SP-2509 engages the endoplasmic reticulum stress response","volume":"17","author":"Pishas","year":"2018","journal-title":"Mol Cancer Ther"},{"key":"bib17","doi-asserted-by":"publisher","first-page":"108286","DOI":"10.1016\/j.exer.2020.108286","article-title":"EPZ015666, a selective protein arginine methyltransferase 5 (PRMT5) inhibitor with an antitumour effect in retinoblastoma","volume":"202","author":"Liu","year":"2021","journal-title":"Exp Eye Res"},{"issue":"4","key":"bib18","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1016\/S0002-9440(10)64653-6","article-title":"Metastatic and nonmetastatic models of retinoblastoma","volume":"157","author":"Ch\u00e9vez-Barrios","year":"2000","journal-title":"Am J Pathol"},{"key":"bib19","first-page":"108304","article-title":"JQ1, a selective inhibitor of BRD4, suppresses retinoblastoma cell growth by inducing cell cycle arrest and apoptosis","author":"Zhang","year":"2020","journal-title":"Exp Eye Res"},{"issue":"8","key":"bib20","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.2217\/epi-2017-0022","article-title":"A comprehensive review of lysine-specific demethylase 1 and its roles in cancer","volume":"9","author":"Hosseini","year":"2017","journal-title":"Epigenomics"},{"issue":"7","key":"bib21","doi-asserted-by":"publisher","first-page":"1658","DOI":"10.1038\/leu.2017.77","article-title":"Highly effective combination of LSD1 (KDM1A) antagonist and pan-histone deacetylase inhibitor against human AML cells","volume":"31","author":"Fiskus","year":"2017","journal-title":"Leukemia"},{"key":"bib22","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/s41392-019-0040-2","article-title":"Epigenetic drug library screening identified an LSD1 inhibitor to target UTX-deficient cells for differentiation therapy","volume":"4","author":"Wu","year":"2019","journal-title":"Signal Transduct Target Ther"},{"issue":"10","key":"bib23","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1016\/j.ophtha.2021.03.018","article-title":"Orbital retinoblastoma treated with intra-arterial chemotherapy","volume":"128","author":"Abramson","year":"2021","journal-title":"Ophthalmology"},{"issue":"4","key":"bib24","doi-asserted-by":"publisher","first-page":"e35065","DOI":"10.1371\/journal.pone.0035065","article-title":"Over-expression of LSD1 promotes proliferation, migration and invasion in non-small cell lung cancer","volume":"7","author":"Lv","year":"2012","journal-title":"PLoS One"},{"issue":"1","key":"bib25","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.canlet.2016.02.004","article-title":"The histone demethylase LSD1 is a novel oncogene and therapeutic target in oral cancer","volume":"374","author":"Wang","year":"2016","journal-title":"Cancer Lett"},{"issue":"2","key":"bib26","doi-asserted-by":"crossref","first-page":"e48597","DOI":"10.15252\/embr.201948597","article-title":"Arginine methylation-dependent LSD1 stability promotes invasion and metastasis of breast cancer","volume":"21","author":"Liu","year":"2020","journal-title":"EMBO Rep"},{"issue":"567","key":"bib27","doi-asserted-by":"publisher","first-page":"eaau2922","DOI":"10.1126\/scisignal.aau2922","article-title":"Targeting NOTCH activation in small cell lung cancer through LSD1 inhibition","volume":"12","author":"Augert","year":"2019","journal-title":"Sci Signal"},{"issue":"1","key":"bib28","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1038\/s41467-018-08269-5","article-title":"Lsd1 as a therapeutic target in Gfi1-activated medulloblastoma","volume":"10","author":"Lee","year":"2019","journal-title":"Nat Commun"},{"key":"bib29","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.canlet.2019.03.052","article-title":"ZY0511, a novel, potent and selective LSD1 inhibitor, exhibits anticancer activity against solid tumors via the DDIT4\/mTOR pathway","volume":"454","author":"Li","year":"2019","journal-title":"Cancer Lett"},{"issue":"11","key":"bib30","doi-asserted-by":"publisher","first-page":"e12525","DOI":"10.15252\/emmm.202012525","article-title":"LSD1 inhibition induces differentiation and cell death in Merkel cell carcinoma","volume":"12","author":"Leiendecker","year":"2020","journal-title":"EMBO Mol Med"},{"issue":"36","key":"bib31","doi-asserted-by":"publisher","first-page":"4260","DOI":"10.1200\/JCO.19.03250","article-title":"First-in-human phase I study of iadademstat (ORY-1001): a first-in-class lysine-specific histone demethylase 1A inhibitor, in relapsed or refractory acute myeloid leukemia","volume":"38","author":"Salamero","year":"2020","journal-title":"J Clin Oncol"},{"issue":"4","key":"bib32","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1038\/onc.2017.353","article-title":"LSD1 promotes S-phase entry and tumorigenesis via chromatin co-occupation with E2F1 and selective H3K9 demethylation","volume":"37","author":"He","year":"2018","journal-title":"Oncogene"},{"issue":"3","key":"bib33","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1016\/j.apsb.2020.06.007","article-title":"Natural products as LSD1 inhibitors for cancer therapy","volume":"11","author":"Fang","year":"2021","journal-title":"Acta Pharm Sin B"},{"issue":"8","key":"bib34","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1093\/abbs\/gmab083","article-title":"SP2509, an inhibitor of LSD1, exerts potential antitumor effects by targeting the JAK\/STAT3 signaling","volume":"53","author":"Zhen","year":"2021","journal-title":"Acta Biochim Biophys Sin (Shanghai)"},{"key":"bib35","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.ejphar.2014.07.025","article-title":"Cisplatin in cancer therapy: molecular mechanisms of action","volume":"740","author":"Dasari","year":"2014","journal-title":"Eur J Pharmacol"},{"issue":"6","key":"bib36","doi-asserted-by":"publisher","first-page":"2713","DOI":"10.3892\/or.2013.2764","article-title":"Anti-apoptotic effect of clusterin on cisplatin-induced cell death of retinoblastoma cells","volume":"30","author":"Song","year":"2013","journal-title":"Oncol Rep"},{"issue":"2","key":"bib37","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1007\/s00280-014-2648-9","article-title":"A multi-institution phase II study of gemcitabine\/cisplatin\/S-1 (GCS) combination chemotherapy for patients with advanced biliary tract cancer (KHBO 1002)","volume":"75","author":"Kanai","year":"2015","journal-title":"Cancer Chemother Pharmacol"},{"issue":"4","key":"bib38","doi-asserted-by":"publisher","first-page":"655","DOI":"10.3727\/096504017X15119525209765","article-title":"Proteasome inhibitor MG132 enhances cisplatin-induced apoptosis in osteosarcoma cells and inhibits tumor growth","volume":"26","author":"Sun","year":"2018","journal-title":"Oncol Res"}],"container-title":["Investigative Opthalmology & Visual Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/iovs.arvojournals.org\/article.aspx?articleid=2778675","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T21:31:33Z","timestamp":1791927093000},"score":1,"resource":{"primary":{"URL":"https:\/\/iovs.arvojournals.org\/article.aspx?articleid=2778675"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,17]]},"references-count":38,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,3,2]]}},"URL":"https:\/\/doi.org\/10.1167\/iovs.63.3.20","relation":{},"ISSN":["1552-5783"],"issn-type":[{"value":"1552-5783","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3,17]]}}}